Stella Pharma Corporation announced a private placement of 4th stock acquisition rights on December 14, 2022. The transaction will include participation from SMBC Nikko Securities Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
345 JPY | +0.29% | +13.91% | +20.70% |
02-13 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
2023 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+20.70% | 68.07M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- 4888 Stock
- News Stella Pharma Corporation
- Stella Pharma Corporation announced that it expects to receive funding from SMBC Nikko Securities Inc.